JP2019520355A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520355A5
JP2019520355A5 JP2018566485A JP2018566485A JP2019520355A5 JP 2019520355 A5 JP2019520355 A5 JP 2019520355A5 JP 2018566485 A JP2018566485 A JP 2018566485A JP 2018566485 A JP2018566485 A JP 2018566485A JP 2019520355 A5 JP2019520355 A5 JP 2019520355A5
Authority
JP
Japan
Prior art keywords
ded
patient
seq
tnfα
response marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018566485A
Other languages
English (en)
Japanese (ja)
Other versions
JP7583515B2 (ja
JP2019520355A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/053625 external-priority patent/WO2017221128A1/en
Publication of JP2019520355A publication Critical patent/JP2019520355A/ja
Publication of JP2019520355A5 publication Critical patent/JP2019520355A5/ja
Priority to JP2022121796A priority Critical patent/JP2022169546A/ja
Application granted granted Critical
Publication of JP7583515B2 publication Critical patent/JP7583515B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018566485A 2016-06-20 2017-06-19 ＴＮＦα拮抗薬を使用したドライアイ疾患の治療方法 Active JP7583515B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022121796A JP2022169546A (ja) 2016-06-20 2022-07-29 ＴＮＦα拮抗薬を使用したドライアイ疾患の治療方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662352091P 2016-06-20 2016-06-20
US62/352,091 2016-06-20
PCT/IB2017/053625 WO2017221128A1 (en) 2016-06-20 2017-06-19 Methods of treating dry eye disease using tnf alpha antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022121796A Division JP2022169546A (ja) 2016-06-20 2022-07-29 ＴＮＦα拮抗薬を使用したドライアイ疾患の治療方法

Publications (3)

Publication Number Publication Date
JP2019520355A JP2019520355A (ja) 2019-07-18
JP2019520355A5 true JP2019520355A5 (https=) 2020-07-30
JP7583515B2 JP7583515B2 (ja) 2024-11-14

Family

ID=59285284

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018566485A Active JP7583515B2 (ja) 2016-06-20 2017-06-19 ＴＮＦα拮抗薬を使用したドライアイ疾患の治療方法
JP2022121796A Pending JP2022169546A (ja) 2016-06-20 2022-07-29 ＴＮＦα拮抗薬を使用したドライアイ疾患の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022121796A Pending JP2022169546A (ja) 2016-06-20 2022-07-29 ＴＮＦα拮抗薬を使用したドライアイ疾患の治療方法

Country Status (6)

Country Link
US (2) US12146187B2 (https=)
EP (1) EP3472203A1 (https=)
JP (2) JP7583515B2 (https=)
CN (1) CN109311976A (https=)
CA (1) CA3032790A1 (https=)
WO (1) WO2017221128A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109311976A (zh) * 2016-06-20 2019-02-05 诺华股份有限公司 使用TNFα拮抗剂治疗干眼症的方法
CN114075597A (zh) * 2020-08-12 2022-02-22 深圳市坪山区人民医院 用于sle易感基因snp检测的核酸组合物、试剂盒及其使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818537A (en) 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US5041434A (en) 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5958912A (en) 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
US5290572A (en) 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5696166A (en) 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
WO2000003705A1 (en) 1998-07-14 2000-01-27 Alcon Laboratories, Inc. Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization
US20090098136A1 (en) * 2007-10-15 2009-04-16 Alcon Research, Ltd. Use of tnf receptor antagonists for treating dry eye
MX345039B (es) 2008-06-25 2017-01-16 Esbatech Alcon Biomed Res Unit Anticuerpos estables y solubles que inhiben el tnfa.
AR083495A1 (es) 2010-10-22 2013-02-27 Esbatech Alcon Biomed Res Unit Anticuerpos estables y solubles
WO2013191352A1 (en) 2012-06-21 2013-12-27 Hanall Biopharma Co., Ltd. New uses of modified human tumor necrosis factor receptor-1 polypeptide
CN109311976A (zh) * 2016-06-20 2019-02-05 诺华股份有限公司 使用TNFα拮抗剂治疗干眼症的方法

Similar Documents

Publication Publication Date Title
JP2015504430A5 (https=)
CN103333952B (zh) 年龄相关的黄斑变性中的遗传多态性
JP5091163B2 (ja) 癌またはその素因の早期検出のための方法およびキット
JP2017513937A5 (https=)
JP2017519498A5 (https=)
RU2014125071A (ru) Способы лечения псориатического артрита (psa) с использованием антагонистов il-17 и аллелей ответа psa или отсутствия ответа psa
RU2016144177A (ru) Способы избирательного лечения астмы с использованием антагонистов il-13
RU2014146594A (ru) Способы лечения анкилозирующего спондилита с использованием антагонистов il-17
CN105636648A (zh) 用于抗tl1a疗法的系统、装置和方法
US20110189685A1 (en) Methods of using jak3 genetic variants to diagnose and predict crohn's disease
JP2017507130A5 (https=)
JP5676623B2 (ja) 加齢黄斑変性における遺伝的多型性
WO2011017120A1 (en) Use of ccr9, ccl25, batf and il17/il23 pathway variants to diagnose and treat inflammatory bowel disease
JP2019520355A5 (https=)
US20120088245A1 (en) Methods of diagnosing insulin resistance and sensitivity
AU2005271244A1 (en) Compositions and methods for determining and predicting treatment responses for depression and anxiety
RU2015144019A (ru) Биомаркеры фармакодинамического ответа опухоли
US20210148910A1 (en) Compositions and methods for treatment of atopic dermatitis and treatment selection
WO2010075584A1 (en) Methods of diagnosing and predicting crohns disease from childhood hygiene and serological profiles
US20170369927A1 (en) Method and device for quantification of target molecules
CN115058512A (zh) 铁死亡相关基因在鉴定缺血性脑卒中的应用
WO2022153323A1 (en) Markers for diagnosing infections
TW200940990A (en) A diagnostic blood test for psychosis
WO2005072152A2 (en) Apoc1 genetic markers associated with age of onset of alzheimer's disease
CN102747075B (zh) 与冠心病相关的6号染色体易感区域标签单核苷酸多态性位点及其组成的单体型与应用